Atlas Trials

Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer

Clinical trial NCT05188716 · COMPLETED

Trial details

NCT number
NCT05188716
Sponsor
Chuangzhen Chen
Status
COMPLETED
Study type
OBSERVATIONAL
Cervical CancerBenign Tumor of Uterus
Start date
2020-12-10
Primary completion
2021-10-13
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.